Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.24911/SJP.106-1587122398 http://scihub22266oqcxt.onion/10.24911/SJP.106-1587122398 32528194!7282440!32528194     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32528194&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Sudan+J+Paediatr 2020 ; 20 (1): 4-9 Nephropedia Template TP {{tp|p=32528194|t=2020. Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19 |pdf=|usr=}}{{32528194}} gab.com Text Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19 JO: Sudan J Paediatr http://www.kidney.de/pget.php?&tw=1&pmid=32528194 #FOAvip Coronavirus disease 2019 (COVID-19) is now spreading as a pandemic ravaging the whole world. In the absence of a vaccine and an effective antiviral chemotherapy, there is currently an intense global interest in repositioning chloroquine (CQ) and its derivative hydroxychloroquine (HCQ) to combat the pandemic. CQ has been used for decades for the treatment and prophylaxis against malaria in endemic countries. It is readily available and has also been manufactured in these countries. CQ is cheap, stable under field conditions and has been well tolerated as an antimalarial. This experience could be adapted to deploy CQ or HCQ for prophylaxis or treatment of COVID19 if strong evidence could be generated for these uses. We believe that well-designed drug trials should be initiated in malaria-endemic countries, taking into account the local context of the epidemic and the capacity of the health system in combating it. In this paper, we are presenting the current status of evidence for using CQ and HCQ against COVID19. Twit Text FOAVip Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19 ????Sudan J Paediatr http://www.kidney.de/pget.php?&tw=1&pmid=32528194 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32528194 #FOAvip English Wikipedia <ref>{{Cite pmid|32528194}}</ref> Perspectives on repositioning chloroquine and hydroxychloroquine for the treatment of Covid-19 #MMPMID32528194 Adeel AA Sudan J Paediatr 2020[]; 20 (1): 4-9 PMID32528194show ga Coronavirus disease 2019 (COVID-19) is now spreading as a pandemic ravaging the whole world. In the absence of a vaccine and an effective antiviral chemotherapy, there is currently an intense global interest in repositioning chloroquine (CQ) and its derivative hydroxychloroquine (HCQ) to combat the pandemic. CQ has been used for decades for the treatment and prophylaxis against malaria in endemic countries. It is readily available and has also been manufactured in these countries. CQ is cheap, stable under field conditions and has been well tolerated as an antimalarial. This experience could be adapted to deploy CQ or HCQ for prophylaxis or treatment of COVID19 if strong evidence could be generated for these uses. We believe that well-designed drug trials should be initiated in malaria-endemic countries, taking into account the local context of the epidemic and the capacity of the health system in combating it. In this paper, we are presenting the current status of evidence for using CQ and HCQ against COVID19. ?Perspectives on repositioning chloroquine and hydroxychloroquine for t(epmc).pdf DeepDyve Pubget Overpricing